Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
510 participants
INTERVENTIONAL
2018-06-08
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Population: The study will be carried out in selected hospitals of the provinces of Mendoza, Tucumán and Salta in Argentina. Patients who have been hospitalized with a diagnosis of heart failure, hypertension (requires hospitalization) and / or coronary disease (unstable angina) will be included.
Design and methods: a Randomized clinical study by clusters. 10 hospital will be included: 5 will be randomly assigned to receive an intervention to increase the improve counter referral rates (improvement cycles) and 5 to the control branch (usual care). 51 participants will be included in each hospital, in total, 510 participants.
Intervention: An innovative vision is proposed, which combines a participatory and dynamic methodology based on improvement cycles. This approach includes the implementation of participatory learning sessions for health providers, involving the effectors of the design of the intervention. In the intervention branch at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices. Each one of the sessions will constitute an analysis of the improvement cycle, following the following steps: 1) Selection of participants of the initial workshop; 2) Development of work model based on bibliographic review and initial qualitative phase; 3) Initial workshop with effectors for training in continuous improvement, objectives, interventions and data collection; 4) Learning workshops to discuss results, applicability of interventions and modifications to the work plan; 5) Closing session to evaluate preliminary results and discuss continuity of interventions beyond the project.
Outcomes: 1) consultation in the PHC after hospital discharge; 2) readmission's; 3) consultations in the hospital; 4) follow-up in the PHC; 5) patient perspective (satisfaction).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Implementation Model for Clinical Decision Support for Heart Failure Prescribing
NCT04028557
Multicenter Study of Generation Comorbidity Score
NCT01346111
Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease
NCT02389153
Experimental Prospective Study on the Effectiveness and Efficiency of the Implementation of Clinical Pathways
NCT00519038
Post-discharge Monitoring of Patients With Heart Failure
NCT03512782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The participants belonging to the hospitals assigned to the control group the health providers will give feedback on their health condition and will advise on how to follow up their care after discharge or referral back to PHC following usual practice.
No interventions assigned to this group
Improvement cycle
In participants belonging to the hospitals assigned to the intervention group,the health providers will give feedback on their health condition and will advise on how to follow up their care after discharge or referral back to PHC using innovative intervention to assure continuity of care and assistant level approach. This innovations will be crafted from the rapid improvement cycles considering the environment and key aspects of the every day care at the participating centers.
Improvement cycle
at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Improvement cycle
at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults over 18 year of age
* Patients admitted to the hospital with diagnosis of: non valvular heart failure and/or complicated hypertension ( that requires hospitalization) and/or coronary heart disease ( unstable angina)
* Residence in the area of influence of the hospitals
Exclusion Criteria
* Anticoagulated patients
* People who are immobilized
* People who do not give their informed consent
* People who plan to move in the next 3 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Public Health, Argentina
OTHER_GOV
Institute for Clinical Effectiveness and Health Policy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vilma Irazola, MD
Role: PRINCIPAL_INVESTIGATOR
Institute for Clinical Effectiveness and Health Policy
Ezequiel García Elorrio, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute for Clinical Effectiveness and Health Policy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital A Italo Perrupato
San Martín, Mendoza Province, Argentina
Hospital Teodoro J. Schestakow
San Rafael, Mendoza Province, Argentina
Hospital Antonio J. Scaravelli
Tunuyán, Mendoza Province, Argentina
Hospital N. Joaquín Castellano
General Güemes, Salta Province, Argentina
Hospital Centro de Salud Zenón J. Santillán
San Miguel de Tucumán, Tucumán Province, Argentina
Hospital Ángel C. Padilla
San Miguel de Tucumán, Tucumán Province, Argentina
Hospital Central
Mendoza, , Argentina
Hospital Luis Lagomaggiore
Mendoza, , Argentina
Hospital Papa Francisco
Salta, , Argentina
Hospital San Bernardo
Salta, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20180328
Identifier Type: OTHER
Identifier Source: secondary_id
C-RG-E1560-P002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.